The  ||| S:0 E:4 ||| DT
use  ||| S:4 E:8 ||| NN
of  ||| S:8 E:11 ||| IN
carotid  ||| S:11 E:19 ||| JJ
ultrasonography  ||| S:19 E:35 ||| NN
in  ||| S:35 E:38 ||| IN
the  ||| S:38 E:42 ||| DT
assessment  ||| S:42 E:53 ||| NN
of  ||| S:53 E:56 ||| IN
subclinical  ||| S:56 E:68 ||| JJ
atherosclerosis  ||| S:68 E:84 ||| NN
and  ||| S:84 E:88 ||| CC
the  ||| S:88 E:92 ||| DT
paradoxical  ||| S:92 E:104 ||| JJ
effect  ||| S:104 E:111 ||| NN
of  ||| S:111 E:114 ||| IN
corticosteroids  ||| S:114 E:130 ||| NN
on  ||| S:130 E:133 ||| IN
atherosclerosis  ||| S:133 E:149 ||| NN
in  ||| S:149 E:152 ||| IN
patients  ||| S:152 E:161 ||| NNS
with  ||| S:161 E:166 ||| IN
rheumatoid  ||| S:166 E:177 ||| FW
arthritis  ||| S:177 E:188 ||| FW
